Area of research
Psychiatry and Mental health · Physiology
Research interest
Research interests include Dementia and Cognitive Impairment Research, Alzheimer's disease research and treatments, Neurobiology of Language and Bilingualism, and Neurological Disease Mechanisms and Treatments.
Cerebrospinal fluid proteomic associations of <i>APOE</i> genotypes reveal distinct protective and risk mechanisms for Alzheimer's disease
Valence as principal dimension of the semantic space in primary progressive aphasia semantic variant
Involvement of the choroid plexus in Alzheimer’s disease pathophysiology: findings from mouse and human proteomic studies
Plasma pTau181 and pTau217 predict asymptomatic amyloid accumulation equally well as amyloid PET
Blood‐based multivariate methylation risk score for cognitive impairment and dementia
Blood DNA methylomic signatures associated with CSF biomarkers of Alzheimer's disease in the EMIF‐AD study
Correction: Pyroptosis in Alzheimer’s disease: cell type‑specific activation in microglia, astrocytes and neurons
Longitudinal associations of serum biomarkers with early cognitive, amyloid and grey matter changes
Longitudinal APOE4- and amyloid-dependent changes in the blood transcriptome in cognitively intact older adults
Longitudinal changes in 18F-Flutemetamol amyloid load in cognitively intact APOE4 carriers versus noncarriers: Methodological considerations
Serum biomarkers for prognosis and monitoring in asymptomatic Alzheimer’s Disease
Pyroptosis in Alzheimer’s disease: cell type-specific activation in microglia, astrocytes and neurons
LATE-NC aggravates GVD-mediated necroptosis in Alzheimer’s disease
Phospho‐specific plasma p‐tau181 assay detects clinical as well as asymptomatic Alzheimer's disease
Classification of 18F-Flutemetamol scans in cognitively normal older adults using machine learning trained with neuropathology as ground truth
Neuronal loss of the nucleus basalis of Meynert in primary progressive aphasia is associated with Alzheimer's disease neuropathological changes
Lack of association between bridging integrator 1 ( <i>BIN1</i> ) rs744373 polymorphism and tau‐PET load in cognitively intact older adults
Baseline cognition is the best predictor of 4-year cognitive change in cognitively intact older adults
Prognostic value of amyloid/tau/neurodegeneration (ATN) classification based on diagnostic cerebrospinal fluid samples for Alzheimer’s disease
Prognostic value of amyloid/tau/neurodegeneration (ATN) classification based on diagnostic cerebrospinal fluid samples for Alzheimer’s disease
Comparison of ELISA- and SIMOA-based quantification of plasma Aβ ratios for early detection of cerebral amyloidosis
Genome-wide association study of Alzheimer’s disease CSF biomarkers in the EMIF-AD Multimodal Biomarker Discovery dataset
Reproducibility of graph measures at the subject level using resting‐state fMRI
Comparison of two analytical platforms for blood‐based surrogate biomarkers of amyloid pathology
Serum neurofilament heavy chains as early marker of motor neuron degeneration
Binding of [18F]AV1451 in post mortem brain slices of semantic variant primary progressive aphasia patients
MRI predictors of amyloid pathology: results from the EMIF-AD Multimodal Biomarker Discovery study
Amnestic MCI patients’ experiences after disclosure of their amyloid PET result in a research context
Core auditory processing deficits in primary progressive aphasia
Amyloid imaging in cognitively normal older adults: comparison between 18F-flutemetamol and 11C-Pittsburgh compound B